Bank Of The West Renovo Rx, Inc. Transaction History
Bank Of The West
- $851 Million
- Q4 2022
A detailed history of Bank Of The West transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Bank Of The West holds 975,000 shares of RNXT stock, worth $1.38 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
975,000
Previous 975,000
-0.0%
Holding current value
$1.38 Million
Previous $1.97 Million
16.29%
% of portfolio
0.27%
Previous 0.26%
Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.92 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$3.24 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.91 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$977,7790.0% of portfolio
-
Bleichroeder LP New York, NY500KShares$710,0000.17% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $12.9M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...